Skip to main content Back to Top
Advertisement

8/10/2022

5% Dextrose Injection Small Volume Bags

Products Affected - Description

    • 5% Dextrose injection, BBraun, 0.9%, 100 mL fill in 150 mL bag, 64 count, NDC 00264-1510-32
    • 5% Dextrose injection, Baxter, 100 mL mini-bag Viaflex flexible container, single 30 count, NDC 00338-9147-30
    • 5% Dextrose injection, Baxter, 50 mL mini-bag Viaflex flexible container, single 30 count, NDC 00338-9143-30
    • 5% Dextrose injection, ICU Medical, 100 mL quad pack flexible container, 20 count, NDC 00990-7923-37
    • 5% Dextrose injection, ICU Medical, 100 mL single flexible container, 48 count, NDC 00990-7923-23
    • 5% Dextrose injection, ICU Medical, 50 mL single bag, 48 count, NDC 00990-7923-13
    • 5% Dextrose injection, ICU Medical, 50 mL quad pack flexible container, 12 count, NDC 00990-7923-36
    • 5% Dextrose injection, Pfizer, 100 mL ADD-Vantage flexible container, 50 count, NDC 00409-7100-67
    • 5% Dextrose injection, Pfizer, 50 mL ADD-Vantage flexible container, 50 count, NDC 00409-7100-66

Reason for the Shortage

    • Baxter did not provide a reason for the shortage.
    • BBraun has 5% dextrose small volume bags on shortage due to labor shortages and manufacturing delays.
    • Fresenius Kabi launched 5% dextrose small volume bags in July 2022.
    • ICU Medical has 5% dextrose small volume bags on shortage due to increased demand.
    • Pfizer has 5% dextrose small volume bags on shortage due to increased demand.

Available Products

    • 5% Dextrose injection, Baxter, 100 mL mini-bag Viaflex flexible container, quad pack 80 count, NDC 00338-0551-18
    • 5% Dextrose injection, Baxter, 50 mL mini-bag Viaflex flexible container, quad pack 80 count, NDC 00338-0551-11
    • 5% Dextrose injection, Fresenius Kabi, 100 mL freeflex+ bag, 50 count, NDC 65219-0236-01
    • 5% Dextrose injection, Fresenius Kabi, 50 mL freeflex+ bag, 60 count, NDC 65219-0234-01
    • 5% Dextrose injection, ICU Medical, 150 mL flexible container, NDC 00990-7922-61
    • 5% Dextrose injection, ICU Medical, 25 mL quad pack bag, 12 count, NDC 00990-7923-20

Estimated Resupply Dates

    • Baxter has 5% dextrose 50 mL bags in 30 count on allocation. The 100 mL bags in 30 count are in limited supply and allocation.
    • BBraun has 5% dextrose 100 mL bags on allocation.
    • ICU Medical has 5% dextrose 50 mL bags in 12 count and 48 count, and 100 mL bags in 20 count on allocation. The 100 mL bags in 48 count are on allocation to contracted customers only.
    • Pfizer has 5% dextrose 50 mL and 100 mL ADD-Vantage bags in limited supply.

Updated

Updated August 10, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 4, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.